IG heavy chain to predict Alzheimer's disease, IG kappa, IG lambda biopolymer markers

摘要

The present invention relates to the use of a combination of preparatory steps with time-of-flight detection mass spectrometry and to maximize the diversity of biopolymers can be verified in a particular specimen. Then, is Kenbun for its ability Teru's evidence the pathology of at least one, the diagnostician, the population of biopolymer that has been validated in such a sample within said at least against the recognition of the presence and / or absence of the biopolymer by it it is possible to inflate a treatment for the disease to obtain the ability to characterize either the presence or absence of a condition of single and predicts the risk assessment of disease.